Cleared Traditional

REPLICA TOTAL HIP SYSTEM (K951741) - FDA 510(k) Clearance

Class II Orthopedic device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1995
Decision
129d
Days
Class 2
Risk

K951741 is an FDA 510(k) clearance for the REPLICA TOTAL HIP SYSTEM. Classified as Prosthesis, Hip, Semi-constrained, Metal/polymer, Porous Uncemented (product code LPH), Class II - Special Controls.

Submitted by Osteo-Technology Intl., Inc. (Hunt Valley, US). The FDA issued a Cleared decision on August 7, 1995 after a review of 129 days - within the typical 510(k) review window.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3358 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all Osteo-Technology Intl., Inc. devices

Submission Details

510(k) Number K951741 FDA.gov
FDA Decision Cleared Substantially Equivalent - NSE Converted (SN)
Date Received March 31, 1995
Decision Date August 07, 1995
Days to Decision 129 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
7d slower than avg
Panel avg: 122d · This submission: 129d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LPH Prosthesis, Hip, Semi-constrained, Metal/polymer, Porous Uncemented
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3358
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - LPH Prosthesis, Hip, Semi-constrained, Metal/polymer, Porous Uncemented

All 325
Devices cleared under the same product code (LPH) and FDA review panel - the closest regulatory comparables to K951741.
PACKAGING AND MANUFACTURING METHODS CHANGE/KNEE COMPONENTS
K936292 · Howmedica Corp. · Aug 1995
DEPUY DURALOC 400 ACETABULAR CUP
K952740 · Depuy, Inc. · Aug 1995
OSTEONICS PS HEMI-HIP STEM SERIES
K933882 · Osteonics Corp. · Aug 1995
VITALOCK SOLID BACKED ACETABULAR SHELL
K952397 · Howmedica Corp. · Jul 1995
SYSTEM 12 P1 26MM ACETABULAR INSERT
K951114 · Howmedica Corp. · Jun 1995
HOWMEDICA VITALOCK 22MM ACERTABULAR SHELL AND SYSTEM 12 INSERTS
K951115 · Howmedica Corp. · Jun 1995